Meetings

Final Agenda

Thursday, May 20, 2010

8:00 am	Welcome Carl June, MD University of Pennsylvania CIS President
8:15 am	Mucosal Immunology Session Chair: Lloyd Mayer, MD, Mount Sinai Medical Center
	8:15 am	Mucosal Immunology and Immune Mediated Disease of the Intestine Lloyd Mayer, MD Mount Sinai Medical Center
	8:45 am	Novel Biologics in IBD Scott Plevy, MD University of North Carolina at Chapel Hill
	9:15 am	Anti-TNF’s Marc Feldman, PhD Imperial College London
	9:45 am	Question & Answer Session
10:00 am	Break
10:30 am	Cancer Immunotherapy Session Co-Chairs: Carl June, MD, University of Pennsylvania Hideho Okada, MD, University of Pittsburgh
	10:30 am	Immunotherapy with iNKT Cells Toshinori Nakayama MD PhD Chiba University
	11:00 am	Emerging Concepts in Biomarker Discovery Relevant to Tumor Immunotherapy Francesco M. Marincola, MD National Institutes of Health
	11:30 am	Pre-surgical Clinical Trials in Cancer Patients to Identify Biomarkers of Immunotherapy Padmanee Sharma, MD PhD MD Anderson Cancer Center
	12:00 pm	Question & Answer Session
12:15 pm	Lunch
1:30 pm	Dermatology Session Chair: Andrew Blauvelt, MD, Oregon Health and Science Universityy
	1:30 pm	Co-morbidities and Psoriasis: Shared Inflammatory Pathways Joel Gelfand, MD University of Pennsylvania
	2:00 pm	Targeted Biologic Therapy for Psoriasis Bruce Strober, MD PhD New York University
	2:30 pm	Role of IL-23 and Th17 Cells in the Pathogenesis of Psoriasis Andrew Blauvelt, MD Oregon Health and Science University
	3:00 pm	Question & Answer Session
3:15 pm	New Therapeutics in Autoimmunity Session Co-Chairs: George Tsokos, MD, Beth Israel Deaconess Medical Center Vasileios Kyttaris, MD, Beth Israel Deaconess Medical Center
	3:15 pm	Larry Moreland, MD University of Pittsburgh Medical Center
	3:45 pm	Biologic Therapy of Autoimmunity: Lessons from Iatrogenic States of Immunodeficiency Leonard Calabrese, DO Cleveland Clinic Foundation
	4:15 pm	Development of a Novel Therapy for Active SLE: Belimumab, a BLyS-Specific Inhibitor William Freimuth, MD PhD Human Genome Sciences
	4:45 pm	Question & Answer Session
5:00 pm	Keynote Address The Future of Immunotherapeutics C. Garrison Fathman, MD Stanford University School of Medicine CIS Past President
5:45 pm	Conclusion of Corporate Thursday

Username:
Password: